Sekondi-Takoradi residents report 75.7% mpox vaccine acceptance
Safety perceptions, effectiveness uncertainty and large neighborhood differences point to targeted communication needs in comparable West African settings.

Peri-urban residents in Sekondi-Takoradi, Ghana, reported 75.7% willingness to accept an mpox vaccine in a community-based cross-sectional medRxiv preprint published Nov. 12.
The Nov. 12 preprint matters because 12.9% of respondents were hesitant and 11.4% refused, suggesting that acceptance was high overall but not uniform across the peri-urban areas studied.
The strongest reported factor associated with acceptance was perceived vaccine safety. Respondents who viewed the mpox vaccine as safe had lower odds of hesitancy, with an adjusted odds ratio of 0.02, and lower odds of refusal, with an adjusted odds ratio of 0.03, according to the preprint.
An adjusted odds ratio compares the odds of an outcome after accounting for variables included in the model. A value below 1 indicates lower odds; a value above 1 indicates higher odds.
Uncertainty about vaccine effectiveness moved in the opposite direction. Respondents unsure about effectiveness had higher odds of hesitancy, with an adjusted odds ratio of 9.83, according to the preprint.
Acceptance also differed sharply by place. Across peri-urban areas in Sekondi-Takoradi, willingness to accept the vaccine ranged from 55.1% to 95.6%, a spread that supports localized public-health messaging rather than a single citywide approach.
The finding is relevant for mpox preparedness in peri-urban West African settings because it identifies specific beliefs linked to vaccine acceptance. The signal from the study is about stated willingness, not actual vaccination uptake.
The study cannot show that improving confidence in safety or effectiveness would by itself raise vaccination rates. Cross-sectional studies capture associations at one point in time and cannot determine whether one factor led to another.
Readers should treat the results as early evidence useful for planning and further study.
Source: academic preprint, medRxiv, Nov. 12, 2026.
Atlas360 reports health research and does not provide medical advice.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- NIH-funded researchers map basal ganglia at single-cell resolution
- PFOS levels track 93% higher aggressive breast cancer rate
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike
- Europe faces attribution gap after 16 cyber, physical incidents

